Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26

This publication has 38 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
  Kidney International, 1996
• The Natural Course of Microalbuminuria in Insulin‐dependent Diabetes: A 10‐year Prospective Study
  Diabetic Medicine, 1995
• Rate of Progression of Albuminuria in Type II Diabetes: Five-year prospective study from South India
  Diabetes Care, 1994
• C-peptide and the classification of diabetes mellitus patients in the Early treatment diabetic retinopathy study report number 6
  Annals of Epidemiology, 1993
• Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus.
  Japanese Journal of Medicine, 1990
• Relation of serum erythropoietin levels to renal excretory function: Evidence for lowered set point for erythropoietin production in chronic renal failure
  The Journal of Pediatrics, 1988
• Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
  New England Journal of Medicine, 1984
• MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
  The Lancet, 1982